Dark Horse Consulting Expands Asia with CJ PARTNERS Deal
Walnut Creek, California & Tokyo, Japan, April 21, 2026 In a strategic move to strengthen its global consulting footprint...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Walnut Creek, California & Tokyo, Japan, April 21, 2026 In a strategic move to strengthen its global consulting footprint...
WINDHAM, New Hampshire | January 6, 2026 — Medicus Healthcare Solutions has released a comprehensive new report examining the...
CALGARY, Alberta — December 4, 2025 — Hemostemix Inc., a leader in autologous stem-cell therapeutics, has appointed Shaune Harding,...
